Rossari Biotech Q1 Results FY27: Net Profit Rises 4.73% to Rs 34 Cr as Revenue Grows 28.23%

Rossari Biotech Q1 results FY27 are out. The company reported a consolidated net profit of Rs 34 Cr for the quarter ended 30 June 2026, up 4.73% from Rs 33 Cr in the year ago quarter, in results announced on Saturday, 18 July 2026.

Shares of Rossari Biotech fell 1.87% to Rs 531.45 on the results day. The company is a specialty chemicals maker serving textiles, home and personal care and animal health. Note: profit growth of 4.73% lagged 28.23% revenue growth, showing margin dilution in the mix.

Click Here – Get Free Investment Predictions

Rossari Biotech Q1 Results FY27 Key Takeaways

Here are the most important numbers from the June 2026 quarter at a glance.

• Net Profit (PAT): Rs 34 Cr in Q1 FY27 versus Rs 33 Cr in Q1 FY26, a change of +4.73% year on year.
• Revenue: Rs 697 Cr in Q1 FY27 versus Rs 543 Cr in Q1 FY26, a change of +28.23%.
• Gross Profit: Rs 55 Cr in Q1 FY27 versus Rs 50 Cr in Q1 FY26, a change of +9.78%.
• Results announced on Saturday, 18 July 2026 for the quarter ended 30 June 2026 on a consolidated basis.
• Rossari Biotech share price fell 1.87% to Rs 531.45 on the results day.

Rossari Biotech Q1 Results FY27 Financial Highlights

The table below summarises the consolidated numbers reported in the Rossari Biotech Q1 results FY27 against the year ago quarter.

Metric	Q1 FY27	Q1 FY26	YoY Change
Revenue	Rs 697 Cr	Rs 543 Cr	+28.23%
Gross Profit	Rs 55 Cr	Rs 50 Cr	+9.78%
Net Profit (PAT)	Rs 34 Cr	Rs 33 Cr	+4.73%

All figures are on a consolidated basis as reported for the quarter ended 30 June 2026.

Rossari Biotech Q1 Results FY27 Performance Analysis

Get Personalised Guidance from a SEBI-Registered Investment Advisor

Profit growth is the headline of the Rossari Biotech Q1 results FY27. Revenue grew 28.23% to Rs 697 Cr from Rs 543 Cr. Gross profit rose 9.78% to Rs 55 Cr from Rs 50 Cr.

The broad based improvement across revenue, gross profit and net profit in the Rossari Biotech Q1 results FY27 suggests the quarter’s growth is operational rather than driven by one off items.

An important context for reading the Rossari Biotech Q1 results FY27: profit growth of 4.73% lagged 28.23% revenue growth, showing margin dilution in the mix.

Rossari Biotech Q1 Results FY27: Key Business Factors

1. Topline Momentum

Revenue grew 28.23% to Rs 697 Cr from Rs 543 Cr. This sets the base against which the rest of the P&L in the Rossari Biotech Q1 results FY27 should be read.

2. Operating Performance

Gross profit rose 9.78% to Rs 55 Cr from Rs 50 Cr. The gross profit trend is the cleanest read on operating health in the quarter.

3. Bottom Line Delivery

The net result of Rs 34 Cr captures the combined effect of operations, other income, finance costs and tax for the quarter.

Dividend Details

Any dividend announcement accompanying the June 2026 quarter results will be reflected in the company’s official NSE and BSE filings. Investors should rely on those filings for dividend confirmation rather than secondary sources.

Rossari Biotech Q1 Results FY27 Outlook for the Full Year

The Rossari Biotech Q1 results FY27 set the tone for FY27. The next markers are the September quarter numbers, any guidance from management, and how costs and demand evolve through the festive half of the year.

Rossari Biotech Stock Performance After the Q1 Results

Download the Univest iOS App or Univest Android App to track Rossari Biotech live share price and upcoming quarterly results.

Rossari Biotech share price fell 1.87% to Rs 531.45 on the results day, as the market weighed the quarter’s numbers against expectations.

Investors can compare the trend of the counter with the Nifty 500 index to judge how the stock is placed relative to the broader market after the June quarter results.

Key Risks

Investors going through the fine print of the Rossari Biotech Q1 results FY27 should also weigh the following risks.

1. Sustaining the Growth Rate

The growth reported in the Rossari Biotech Q1 results FY27 sets a higher base for coming quarters, and any moderation could disappoint a market that extrapolates.

2. Margin Durability

Whether the quarter’s operating performance holds depends on input costs, pricing power and mix, all of which can shift quickly.

3. Execution and External Risks

Demand cycles, regulatory changes and sector specific shocks remain outside management control and can reset expectations.

Conclusion

Rossari Biotech Q1 results FY27 show consolidated net profit of Rs 34 Cr for the quarter ended 30 June 2026, up 4.73% from Rs 33 Cr in the year ago quarter. Revenue grew 28.23% to Rs 697 Cr from Rs 543 Cr. The September quarter will show whether this quarter’s trend extends. Investors should verify the filings on NSE and BSE and consult a SEBI-registered advisor before acting on the numbers.

Frequently Asked Questions on Rossari Biotech Q1 Results FY27

When were the Rossari Biotech Q1 results FY27 announced?

Ans. The Rossari Biotech Q1 results FY27 were announced on Saturday, 18 July 2026, for the quarter ended 30 June 2026, on a consolidated basis.

What is the PAT in the Rossari Biotech Q1 results FY27?

Ans. The consolidated PAT in the Rossari Biotech Q1 results FY27 stood at Rs 34 Cr, a change of +4.73% from Rs 33 Cr in Q1 FY26.

What was the revenue in the Rossari Biotech Q1 results FY27?

Ans. The revenue in the Rossari Biotech Q1 results FY27 stood at Rs 697 Cr, a change of +28.23% from Rs 543 Cr in Q1 FY26.

What was the gross profit in the Rossari Biotech Q1 results FY27?

Ans. Gross profit for the June 2026 quarter stood at Rs 55 Cr, compared with Rs 50 Cr in Q1 FY26, a change of +9.78% year on year.

Are the Rossari Biotech Q1 results FY27 standalone or consolidated?

Ans. The figures discussed here are on a consolidated basis, as reported for the quarter ended 30 June 2026.

How did the share price react after the Rossari Biotech Q1 results FY27?

Ans. Rossari Biotech share price fell 1.87% to Rs 531.45 on the results day.

Is the stock a good buy after the Rossari Biotech Q1 results FY27?

Ans. The Rossari Biotech Q1 results FY27 are one input among many. Valuation, sector conditions and risk appetite matter as much as a single quarter. This article is for educational purposes only. Consult a SEBI-registered advisor before investing.

Where can I verify the Rossari Biotech Q1 results FY27?

Ans. The official filings for the Rossari Biotech Q1 results FY27 are available on the NSE and BSE websites, and the stock can be tracked on the Univest app.